[ET Net News Agency, 22 March 2024] IMMUNEONCO-B (01541) rose 32.6% to HK$19.62,
breaking above the 20-D SMA of HK$18.546.
It hits an intra-day high of HK$20, and an intra-day low of HK$14.5. The total shares
traded was 330,600, with a value of HK$5.75m. The active buy/sell ratio is 60:40, with net
buying turnover of HK$1.09m. CHINA INV INFO accounts for greatest net responsive buying
turnover of HK$669,132, with volume weighted average price of HK$18.28. CHINA SEC INT'L
BRO accounts for greatest net responsive selling turnover of HK$521,600, with volume
weighted average price of HK$14.903.
Basic Information
=================
-----------------------------------
Nominal 19.620 % Chg +32.57%
High 20.000 Low 14.500
Shares Tr 330,600 Turnover 5.75m
10-D SMA 17.296 %H.V 190.320
20-D SMA 18.546 VWAP 17.393
50-D SMA 21.473 RSI14 51.956
-----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 60:40, with net buying
turnover of HK$1.09m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
IMMUNEONCO-B (01541) 19.62 +32.57
HUTCHMED (00013) 26.40 -3.65
GENSCRIPT BIO (01548) 14.68 -5.41
INNOVENT BIO (01801) 35.75 -6.17
EVEREST MED-B (01952) 23.70 -5.58
WUXI BIO (02269) 13.30 -6.34
TIGERMED (03347) 29.70 -4.96
BEIGENE (06160) 95.90 -5.33
AKESO (09926) 46.00 -3.36
REMEGEN (09995) 25.80 -7.03
---------------------------------------------
(ed)